PI
IRWD icon

PEAK6 Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

PEAK6 Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,313
Closed -$220K – 4210
2018
Q4 		$220K Buy
+25,313
New +$290K ﹤0.01% 2961

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

PEAK6 Investments's IRWD Position: Q1 2019 in Review

PEAK6 Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 9,883 shares — an estimated $86K sold.

PEAK6 Investments first reported a position in IRWD in Q4 2018 and held it in 1 quarter. The position peaked at $86K in Q4 2018. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

  • PEAK6 Investments reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • PEAK6 Investments sold 9,883 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $86K.
  • PEAK6 Investments first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • PEAK6 Investments's Ironwood Pharmaceuticals position peaked at $86K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on PEAK6 Investments's 13F filing for Q1 2019, filed 15 May 2019.